Examining the Role of Telemedicine in Diabetic Retinopathy

With the increasing prevalence of diabetic retinopathy (DR), screening is of the utmost importance to prevent vision loss for patients and reduce financial costs for the healthcare system. Unfortunately, it appears that the capacity of optometrists and ophthalmologists to adequately perform in-person screenings of DR will be insufficient within the coming years. Telemedicine offers the opportunity to expand access to screening while reducing the economic and temporal burden associated with current in-person protocols. The present literature review summarizes the latest developments in telemedicine for DR screening, considerations for stakeholders, barriers to implementation, and future directions in this area. As the role of telemedicine in DR screening continues to expand, further work will be necessary to continually optimize practices and improve long-term patient outcomes.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Journal of clinical medicine - 12(2023), 10 vom: 18. Mai

Sprache:

Englisch

Beteiligte Personen:

Land, Matthew R [VerfasserIn]
Patel, Parth A [VerfasserIn]
Bui, Tommy [VerfasserIn]
Jiao, Cheng [VerfasserIn]
Ali, Arsalan [VerfasserIn]
Ibnamasud, Shadman [VerfasserIn]
Patel, Prem N [VerfasserIn]
Sheth, Veeral [VerfasserIn]

Links:

Volltext

Themen:

Artificial intelligence
Diabetic retinopathy
Journal Article
Multidisciplinary cooperation
Review
Telemedicine
Teleophthalmology

Anmerkungen:

Date Revised 30.05.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/jcm12103537

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM357428684